Worth reading
43Recurring
Scored from 4 of 5 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
250000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the 19th Stock Acquisition Rights issued through third-party allotment (with Exercise Price Adjustment Clause)
Who receives how much
Number of shares delivered during the month: 250,000 shares (250,000 new shares, 0 treasury shares transferred)
EVO FUND (the allottee at the time of issuance on 8 August 2025)
The lower thin line represents the existing number of shares to which these shares will be added.
発行済株式総数
Exercise ratio under the exercise limit: 0.6% (250,000 shares / 44,613,940 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the subject month: ¥64–¥78 per share. The rights have an exercise price adjustment clause, but the adjustment floor was Not disclosed
Number of Stock Acquisition Rights
Total issued: 110,000 rights; unexercised balance at the end of the month preceding the subject month: 85,000 rights; unexercised balance at the end of the subject month: 82,500 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
8 August 2025: Issuance of the 19th Stock Acquisition Rights to be allotted to EVO FUND (see the materials released on 23 July 2025 for details)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 19th Stock Acquisition Rights issued through third-party allotment (with Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 250,000 shares (250,000 new shares, 0 treasury shares transferred) |
| Intended allottee | EVO FUND (the allottee at the time of issuance on 8 August 2025) |
| Dilution Rate | Exercise ratio under the exercise limit: 0.6% (250,000 shares / 44,613,940 shares) |
| Total number of issued shares | 56,832,640 shares (as of the end of the month preceding the subject month) → Not disclosed |
| Exercise price | Exercise price during the subject month: ¥64–¥78 per share. The rights have an exercise price adjustment clause, but the adjustment floor was Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 110,000 rights; unexercised balance at the end of the month preceding the subject month: 85,000 rights; unexercised balance at the end of the subject month: 82,500 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | 8 August 2025: Issuance of the 19th Stock Acquisition Rights to be allotted to EVO FUND (see the materials released on 23 July 2025 for details) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 19th Stock Acquisition Rights in October 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.